Abstract:Drug resistance and metastasis are considered to be the major factors leading to tragic prognosis and high rate of mortality in cancer patients. Recent evidences suggest that cancer stem cells (CSCs) possess the essential property of self‐protection from chemotherapy, exhibit the ability to self‐renew and generate cancer cells by asymmetric cell division. Nevertheless, the currently known mechanisms likely explain only the tip of an iceberg about CSC property, acquisition and maintenance. The information from data mining is still limited due to the rarity of CSCs in clinical samples. Ovarian cancer is the most lethal malignancy of the female reproductive system. CSCs in ovarian cancers are considered to acquire the molecular armaments of stem cells, which carry stem cell property and can determine the level of malignant potential of the cancer cells, similar to the findings in other cancer cell types. To overcome the limitation and assess the underlying mechanism, we introduced a set of defined factors (OCT3/4, SOX2, KLF4 and c‐Myc) into human serous ovarian cancer cells, which is one of the most frequently encountered ovarian cancer type in female, through Sendai virus reprogramming, aiming to induce CSC properties in the cancer cells. We then evaluated the CSC properties in the cells. In preliminary data, we observed that the ovarian cancer cells transduced with the four Yamanaka factors showed significantly enhanced pluripotent stem cell properties and drug resistance. We thus named the cells with CSC properties as induced ovarian CSCs (iOCSCs). These iOCSCs could be maintained and expanded up to at least 40 passages. Notably, consistent with the original ovarian cancer cells, iOCSCs could be differentiated into ovarian lineage cells, displaying markers as CA125 and CK‐7, shows that we generate generated iOCSCs with lineage specificity directly from cancer cells. In addition, we also confirmed that the phenotypes of our iOCSCs were reproducible in organoid culture and serial transplantation. The next, we are going to analysis the gene expression, transcriptome and metabolomics in iOCSCs to fully understand CSCs and find out new therapies target. Intriguingly, iOCSCs also acquired the ability to differentiate into cells belonging to the three embryonic germ layers, similar to human iPS cells or ES cells, this finding is probably the dawn of uncovering the stem cell tumorigenecity. It is worth to emphasize again, this great value present approach thus makes it feasible to obtain abundant CSCs to support our understanding and in‐depth research into CSCs and hopefully can help in developing new therapeutic strategies to treat ovarian cancers. Support or Funding Information National Science Council of the Republic of China (NSC) and National Taiwan University Hospital (NTUH), Taiwan

Human Ovarian Cancer Stem-Like Cells Can Be Efficiently Killed by Γδ T Lymphocytes

Ovarian carcinoma cells inhibit CD 69 expression in CD 8+T cells

Ovarian Carcinoma Cell Supernatants Inhibit Proliferation and IL-2R Expression of CD8~+ T Cell

Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line

Eliciting Effective Tumor Immunity Against Ovarian Cancer by Cancer Stem Cell Vaccination

Ovarian caremoma cell supernatants inhibit proliferation and IL-2R expression of CD8+ T cell

Ovarian Carcinoma Cells Inhibit T Cell Proliferation: Suppression of IL-2 Receptor Β and Γ Expression and Their JAK-STAT Signaling Pathway

Effect of targeted ovarian cancer immunotherapy using ovarian cancer stem cell vaccine

Are Ovarian Cancer Stem Cells the Target for Innovative Immunotherapy?

Human Ovarian Carcinoma Cells Generate CD4+CD25+ Regulatory T Cells from Peripheral CD4+CD25− T Cells Through Secreting TGF-β

Research on the Immune Response of Ovarian Cancer Cell Line Derived Cancer Stem Cells

Cancer Stem-Like Cells Can Be Isolated with Drug Selection in Human Ovarian Cancer Cell Line SKOV3.

Isolation and culture of cancer stem cells from ovarian cancer tissues and malignant ascites

Establishment of Specific Cytotoxic T Lymphocyte Culture System and Its Inhibitory Effect on Ovarian Cancer

Human Epithelial Ovarian Carcinoma Cell-Derived Cytokines Cooperatively Induce Activated Cd4+Cd25-Cd45ra+Naive T Cells To Express Forkhead Box Protein 3 And Exhibit Suppressive Ability In Vitro

Enrichment and Characterization of Ovarian Cancer Stem Cells and Its Potential Clinical Application

[Ovarian carcinoma cell inhibits T cell JAK-STAT signal transduction pathway, an experimental study].

Propagating the Ovarian Cancer Stem Cells by Reprogramming the Tumor Cells

Establishment and identification of specific cytotoxic T lymphocyte in vitro culture system and the effect on ovarian cancer cells

Isolation and characterization of cancer stem cells from high-grade serous ovarian carcinomas.

How to win the ovarian cancer stem cell battle: destroying the roots